Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00005053-198305000-00011 | DOI Listing |
J Clin Psychiatry
October 1988
Department of Psychiatry, St. Michael's Hospital, Toronto, Ontario, Canada.
Two patients with depression that was refractory to tricyclic antidepressant therapy alone and in combination with lithium or triiodothyronine (T3) were treated with the monoamine oxidase inhibitor phenelzine. In both cases, the addition of T3 potentiated the antidepressant response to phenelzine. These observations suggest that thyroid hormone potentiation may not be specific to one class of antidepressant drugs.
View Article and Find Full Text PDFEighty-two patients suffering from panic attacks with or without phobias were examined for evidence of thyroid disease. None of the patients had abnormal total T4 or T3 resin uptake measurements, regardless of whether they were nonmedicated or treated with one of three antipanic drugs: alprazolam, phenelzine, or imipramine. A higher than expected incidence of undetectable TSH levels (22% overall) appeared in all groups.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!